Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections
Stem Cell Res Ther. 2025 May 1;16(1):215. doi: 10.1186/s13287-025-04316-3. ABSTRACT BACKGROUND: Preliminary phase I clinical trial results revealed that autologous umbilical cord blood-derived mononuclear cells …